Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...
Please provide your email address to receive an email when new articles are posted on . Use of hydroxyurea did not reduce ovarian reserve among girls and young women with sickle cell disease.
Hydroxyurea may falsely elevate sensor glucose results from certain CGM systems. The prescribing information for hydroxyurea has been updated to include information regarding patients who use ...
(WASHINGTON, July 18, 2024) – In female patients living with sickle cell disease (SCD), hydroxyurea had no effect on ovarian reserve, suggesting that fertility preservation measures prior to treatment ...
Hematologic DLTs -- mostly mild and transient -- occurred in 33% of patients taking hydroxyurea compared with 11% of patients taking placebo -- a difference of 22 percentage points (95% CI 11-34), ...
Researchers have revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia. Their findings enhance strong evidence of hydroxyurea's effectiveness and could ...
Hydroxyurea does not significantly reduce ovarian reserve in girls and women with sickle cell disease. Fertility preservation measures before hydroxyurea treatment may not be necessary. The study ...
Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical ...
Hosted on MSN
New intervention may be a path to a better quality of life for adolescents with sickle cell disease
A novel intervention aimed at helping adolescents with sickle cell disease maintain hydroxyurea treatment plans shows promising results at improving their quality of life, a new Columbia University ...
Machine learning identified RDW and HGB as key predictors of hydroxyurea resistance in polycythemia vera, aiding early identification and treatment adjustment. The PV-AIM study used electronic health ...
From Left- Yunigen President and Scientific Officer Wyclifee Omwancha, and Dr. Musalia Mudavadi, Prime Cabinet Secretary and Cabinet Secretary for Foreign & Diaspora Affairs for the Republic of Kenya ...
Zinc for Infection Prevention in Sickle Cell Anemia study leaders Chandy John, far left; Ruth Namazzi, second from right; and Robert Opoka, far right; with Justin Brown, second from left, and Aaron ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results